Bachem showcasing advanced ‘tides capabilities’ at CPhI North America

Bubendorf, Switzerland: –Peptide and Oligonucleotide technology specialist Bachem will again be a prominent exhibitor at the upcoming CPhI North America trade fair in Philadelphia.

Bachem Americas, Inc. will have a stand at Booth 1609 at the Pennsylvania Convention Center, as part of the main CPhI Ingredients and Excipients Zone.

Bachem team

Leading the Bachem team for CPhI NA will be Eric Bouillet Senior Director and Head of Generics for the Americas at Bachem, along with Business Development Managers Tim Morgan and Keith Porter.

Together, they will showcase Bachem’s ever-expanding portfolio of CMO capabilities, expanding from peptides into oligonucleotide (oligomers) alongside generic APIs and research molecules with GMP manufacturing expertise across the range.

They will also be able to answer technical inquiries and show ways in which Bachem can support the success of client projects from initiation, through all clinical development phases to commercial supply.

Oligomer expansion

Together they will be dedicated to face-to-face meetings with existing and potential customers from across North America.

The display will focus on Bachem’s recent achievements in leveraging it decades of experience in the development, production and regulatory support of peptides and generic APIs into rapidly establishing world-class capabilities in oligonucleotides, including GMP manufacturing.

Bachem has a well-founded relationship with CPhI North America, having attended the event almost every year since it was first established in 2017.

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.

Further information at: www.bachem.com

About CPhI North America

CPhI North America made its debut in 2017 as a new development of the highly successful CPhI worldwide franchise first established in 1989. Originally conceived as a chemical and pharmaceutical ingredients show, CPhI is now a global series of events for the whole pharmaceutical value chain, taking in events all over the world attracting more than 100,000 attendees annually.

CPhI NA is branded as seven shows in one, co-locating CPhI Connect for pharmaceutical ingredients with six other zones, including Informex (fine and specialty chemicals), iCSE (drugs development) FDF (finished drug products), P-Mec (Machinery), and InnoPack for packaging.

The fifth CPhI North America Expo is a hybrid ‘Smart Event’, combining all the face to face interaction of being onsite with an online platform to form a holistic event.

The three-day face-to-face expo opens  May 17, 2022, once again at the Pennsylvania Convention Center in Philadelphia, preceded by an online seminar program covering three tracks: US Market Insights, Product Innovation and Future Forecasting, Diversity, Equality, and Inclusion, as well as networking via Informa’s new Swapcard platform.

CPhI North America is staged by leading Global B2B events organizer and publisher Informa, with further information at: https://www.cphi.com/northamerica/en/home.html

Resources

Click on Bachem at CPhI North America to view exhibitor profile for the event.
Click on Oligonucleotides – Innovation that transforms lives to watch video.
Click on Expanding into Oligos: Interview to watch video.
Click on Bachems News to see latest News & Events.